Leweke FM et al. |
Elevated endogenous cannabinoids in schizophrenia. |
1999 |
Neuroreport |
pmid:10501554
|
Kuwae T et al. |
Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages. |
1999 |
FEBS Lett. |
pmid:10508930
|
Wiley JL |
Cannabis: discrimination of "internal bliss"? |
1999 |
Pharmacol. Biochem. Behav. |
pmid:10515300
|
Walker JM et al. |
Pain modulation by release of the endogenous cannabinoid anandamide. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10518599
|
Katayama K et al. |
Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme. |
1999 |
Biochim. Biophys. Acta |
pmid:10521704
|
Chaytor AT et al. |
The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. |
1999 |
J. Physiol. (Lond.) |
pmid:10523421
|
McAllister SD et al. |
Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. |
1999 |
J. Pharmacol. Exp. Ther. |
pmid:10525080
|
Yousif MH and Oriowo MA |
Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments. |
1999 |
Pharmacol. Res. |
pmid:10527656
|
Akinshola BE et al. |
Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. |
1999 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10543424
|
Gifford AN et al. |
Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). |
1999 |
Eur. J. Pharmacol. |
pmid:10556675
|
Járai Z et al. |
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10570211
|
Bisogno T et al. |
Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. |
1999 |
Arch. Biochem. Biophys. |
pmid:10577359
|
Melck D et al. |
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. |
1999 |
FEBS Lett. |
pmid:10606728
|
Melck D et al. |
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. |
2000 |
Endocrinology |
pmid:10614630
|
Sugiura T et al. |
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. |
2000 |
J. Biol. Chem. |
pmid:10617657
|
Sinor AD et al. |
Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. |
2000 |
Neurosci. Lett. |
pmid:10653017
|
Zygmunt PM et al. |
Anandamide - the other side of the coin. |
2000 |
Trends Pharmacol. Sci. |
pmid:10664604
|
Schmid PC et al. |
A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. |
2000 |
Chem. Phys. Lipids |
pmid:10669310
|
Tiger G et al. |
Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate. |
2000 |
Biochem. Pharmacol. |
pmid:10677581
|
Griffin G et al. |
Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10688601
|